YL202/BNT326, a HER3-targeted ADC, in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Breast Cancer: Preliminary Results from a First-in-human Phase I Trial.
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要